Keyphrases
Spain
100%
Direct Susceptibility
50%
Liquid Culture
50%
Stool Antigen
50%
Eradication Therapy
50%
Helicobacter Pylori (H. pylori)
50%
Helicobacter Pylori Infection
50%
Enzyme-linked Immunosorbent Assay (ELISA)
50%
Immunoassay Methods
50%
Cardiac Surgery
50%
Blood Culture Bottles
50%
Direct Identification
50%
Serum Concentration
50%
Mycobacterial Species
50%
MicroScan
50%
Large Cohort
50%
Disease Severity
50%
Procalcitonin
50%
COVID-19
50%
Humoral Immune Response
50%
INNO-LiPA
50%
Mycobacterium
50%
Vitek 2 Compact
50%
Gram-negative Bacilli
50%
Genotype
50%
Susceptibility Testing
50%
COVID-19 Pandemic
50%
Healthcare Workers
50%
Female Sex Workers
50%
Sexually Transmitted Infections
50%
Risk Difference
50%
Risk Behavior
50%
AIDS/HIV
50%
Social Characteristics
50%
Characteristic Risk
50%
Catalonia
50%
Actinobaculum Schaalii
50%
Tuberculosis Bacilli
50%
Bacterial Identification
50%
Aerococcus
50%
Urinary Tract Infection
50%
Lower Respiratory Tract Infection
50%
In Vivo Model
50%
Murine Model
50%
Bacillus
50%
Accessory Genes
50%
MALDI-TOF
50%
Staphylococcus Aureus
50%
Mycobacterium Tuberculosis (M. tb)
50%
Pseudomonas Aeruginosa (P. aeruginosa)
37%
Immunology and Microbiology
Experimental Model
50%
Humoral Immunity
50%
Aerococcus
50%
Bacterium Identification
50%
Mycobacteria
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Matrix-Assisted Laser Desorption-Ionization
50%
Mycobacterium Tuberculosis
50%
Lower Respiratory Tract
50%
Mycoplasma pneumoniae
50%
Gram-Negative Bacteria
50%
Immunoglobulin M
50%
Urinary Tract
50%
COVID-19
50%
Staphylococcus Aureus
50%
Pseudomonas aeruginosa
50%
Molecular Typing
50%
Regulator Gene
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
36%
Immunology
33%
Escherichia coli
33%
Enterobacter Cloacae
33%
Colony-Forming Unit
25%
Sigma Factor
25%
Colony Forming Unit S
25%
Tumor Necrosis Factor
25%
T Cell
25%
Murine
25%
Enterobacteriaceae
16%
Klebsiella oxytoca
16%
Clinical Microbiology
16%
Klebsiella pneumoniae
16%
Infectious Disease
16%
Centrifugation
16%
Respiratory Virus
12%
RNA Gene
12%
Immunosuppression
8%
Microbial Growth
8%
Infectious Agent
8%
Spike
8%
Virus Nucleocapsid
8%
Immune Response
8%
Microbiology
8%
Serology
6%
Mycobacterium kansasii
6%
Pyrosequencing
6%
Tandem Repeat
6%
Coinfection
6%
DNA Microarray
5%
Medicine and Dentistry
Human Immunodeficiency Virus
50%
Prevalence
50%
Blood Culture
50%
Gram-Negative Bacteria
50%
Mycobacteria
50%
Attributable Risk
50%
High Risk Behavior
50%
Heart Surgery
50%
Procalcitonin
50%
Lower Respiratory Tract Infection
50%
Matrix-Assisted Laser Desorption-Ionization
50%
Bacterium Identification
50%
Aerococcus
50%
Mycoplasma Pneumonia
50%
Urinary Tract Infection
50%
Regulator Gene
50%
Molecular Typing
50%
Staphylococcus Aureus
50%
Macrolide
50%
Infection
35%
Pseudomonas aeruginosa
30%
Client
25%
Neisseria gonorrhoeae
25%
Human Immunodeficiency Virus Prevalence
25%
Escherichia coli
20%
Enterobacter Cloacae
20%
RNA 23S
18%
Malignant Neoplasm
16%
Immigrant
12%
Coitus
12%
Condom Use
12%
Chlamydia Trachomatis
12%
Neisseria
12%
Urine Sampling
12%
Cross Sectional Study
12%
Cardiopulmonary Bypass
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Bloodstream Infection
11%
Klebsiella oxytoca
10%
Enterobacteriaceae
10%
Klebsiella pneumoniae
10%
Mass Spectrum
8%
Pathogen
8%
Diabetes
8%
Genitourinary System
8%
Catheterization
8%
Elderly Patient
8%
Microbial Growth
8%
Immunosuppressive Treatment
8%
Isoniazid
6%
